Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder. That means only one copy of the altered gene is needed to cause the condition. If a parent has NF1, each child has a 50% chance of inheriting it.
What Autosomal Dominant Means for NF1
Everyone carries two copies of the NF1 gene, one from each parent. In autosomal dominant inheritance, a single faulty copy is enough to produce the condition. You don’t need to inherit the mutation from both parents, and there’s no “carrier” state where someone has the gene change without any effects. If you have the mutation, you have NF1.
The NF1 gene sits on chromosome 17 and provides instructions for making a protein called neurofibromin. This protein acts as a brake on cell growth by switching off a signaling pathway that tells cells to multiply. When one copy of the gene is defective, that braking system is weakened, which leads to the characteristic features of the condition: skin-colored bumps called neurofibromas, flat light-brown patches on the skin (café-au-lait spots), and freckling in the armpits or groin.
Dominant in the Person, Recessive in the Cell
There’s a nuance that sometimes causes confusion. NF1 is dominant at the level of the whole person, meaning one mutated copy causes the disorder. But at the cellular level, tumor formation often follows a “two-hit” model. The first hit is the inherited mutation present in every cell. The second hit is a new, random mutation that knocks out the remaining working copy of the gene in a specific cell. When both copies are lost in a single cell, that cell loses its growth brake entirely and can form a neurofibroma or, less commonly, a malignant tumor.
Research published in the American Journal of Human Genetics confirmed this double-inactivation pattern in benign neurofibromas, finding mutations in both copies of the NF1 gene within tumor tissue. This explains why people with NF1 develop tumors in some locations but not others: the second hit occurs randomly and only affects certain cells over a lifetime.
Half of All Cases Are New Mutations
About 50% of people with NF1 inherited the mutation from a parent who also has the condition. The other 50% have a brand-new (de novo) mutation that arose spontaneously, with no family history at all. The NF1 gene is large, which makes it a relatively easy target for random genetic errors during DNA replication.
Regardless of whether the mutation was inherited or spontaneous, the pattern going forward is the same. Once someone has NF1, each of their future children faces a 50% chance of inheriting it.
Penetrance and Variable Severity
NF1 has complete or near-complete penetrance, meaning virtually everyone who carries the mutation will show some signs of the disorder by a certain age. However, those signs can range dramatically in severity, even within the same family. One person might have only a handful of café-au-lait spots and mild freckling, while a sibling with the identical mutation develops hundreds of neurofibromas or complications like optic pathway tumors or bone abnormalities. This unpredictability is called variable expressivity, and researchers still don’t fully understand what drives it.
Mosaic NF1: A Special Case
A small subset of people have mosaic (sometimes called segmental) NF1. In this form, the mutation doesn’t occur in the egg or sperm but arises after fertilization, during early embryonic development. The result is that only some cells in the body carry the mutation, typically producing features limited to one area of the body rather than widespread involvement.
In a study of 60 children with mosaic NF1, 77% had findings on only one side of the body, and 65% initially presented with localized pigmentary changes alone. Mosaic NF1 is often milder, but it still carries the potential for complications in the affected region. Importantly, if the mutation is present in a person’s reproductive cells, they can pass full NF1 to their children, even if their own symptoms are limited.
How NF1 Is Diagnosed
Doctors use a set of clinical criteria updated in 2021 by an international consensus panel. For someone without a parent diagnosed with NF1, two or more of the following must be present:
- Café-au-lait spots: six or more, larger than 5 mm in children or 15 mm after puberty
- Freckling: in the armpits or groin
- Neurofibromas: two or more of any type, or one plexiform neurofibroma
- Optic pathway glioma: a tumor along the nerve connecting the eye to the brain
- Lisch nodules: two or more small, harmless growths on the colored part of the eye, visible with a special lamp
- Bone abnormalities: such as bowing of the shin bone or thinning of a skull bone
- Genetic testing: a confirmed NF1 gene mutation in a blood sample
If a parent already has a confirmed diagnosis, only one of the above signs is needed in a child to establish the diagnosis.
How Common NF1 Is
NF1 is one of the most common single-gene disorders in humans. A 2023 meta-analysis pooling data from over 11.6 million individuals estimated the prevalence at roughly 1 in 3,000 to 1 in 4,000 people. Studies that actively screened populations found higher rates (about 1 in 2,000), suggesting many mild cases go unrecognized through routine medical records alone.